13F-HR filed by Trails Edge Capital Partners, LP
Trails Edge Capital Partners, LP filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 27 holding rows worth $436,527,522.
- Accession
- 0002077247-26-000003
- Filer
- CIK 2077247
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 27 entries on the cover page, a total value of $436,527,522 stated on the cover page (in dollars after the unit check, H1), rows summing to $436,527,522 with VALUE read as dollars as filed, 13F file number 028-26566. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VAXCYTE INC COM | 92243G108 | Stock | 662,470 | $38,496,132 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 1,738,110 | $32,850,280 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 1,319,362 | $32,535,467 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 333,312 | $30,791,363 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 1,743,220 | $27,019,910 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 440,000 | $25,586,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 245,000 | $23,826,250 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 1,047,935 | $22,635,396 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 682,597 | $20,580,300 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 300,000 | $19,773,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 701,821 | $16,394,539 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 782,787 | $15,780,986 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 2,657,997 | $14,751,883 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 8,057,345 | $13,536,340 | dollars as filed | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 1,302,917 | $12,130,157 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 200,000 | $11,630,000 | dollars as filed | put |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 2,571,478 | $10,620,204 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 414,054 | $10,285,102 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 852,013 | $9,065,418 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 1,939,563 | $8,553,472 | dollars as filed | |
| MINERVA NEUROSCIENCES INC | 603380205 | COM NEW | 1,419,000 | $8,549,475 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M505 | COM SHS | 557,103 | $7,075,208 | dollars as filed | |
| SOL-GEL TECHNOLOGIES LTD | M8694L137 | SHS NEW | 85,496 | $6,772,993 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 2,449,993 | $5,536,984 | dollars as filed | |
| VTV THERAPEUTICS INC | 918385204 | CL A NEW | 139,578 | $5,535,663 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 125,000 | $3,940,000 | dollars as filed | |
| OPUS GENETICS INC | 67577R102 | COMMON STOCK | 500,000 | $2,275,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0002077247-26-000003 | this filing | 2026-05-15 | acceptance time not in the bulk data set |